CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation

Introduction: There are still no effective diagnostic and prognostic biomarkers in pancreatic ductal adenocarcinoma (PDAC). The differentiation between PDAC and chronic pancreatitis (CP) is often challenging. The inflammatory mass in the course of CP causes diagnostic difficulties in differentiating...

Descripción completa

Detalles Bibliográficos
Autores principales: Wlodarczyk, Barbara, Durko, Lukasz, Wlodarczyk, Przemyslaw, Talar-Wojnarowska, Renata, Malecka-Wojciesko, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299217/
https://www.ncbi.nlm.nih.gov/pubmed/37373743
http://dx.doi.org/10.3390/jcm12124050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299217/
https://www.ncbi.nlm.nih.gov/pubmed/37373743
http://dx.doi.org/10.3390/jcm12124050

Ejemplares similares